Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MBOAT4 | Q96T53 | 6/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.41 |
| ▸ | HPGD | P15428 | 3/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 3/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | PDE2A | O00408 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8487840 | 0.85 | KDM4E (0.40) | MBOAT4ALDH1A1KDM4EHPGDPOLB | |
| SCHEMBL4813093 | 0.81 | TSHR (0.42) | MBOAT4ALDH1A1KDM4EHPGDPOLB | |
| SCHEMBL4814224 | 0.80 | POLB (0.47) | MBOAT4ALDH1A1KDM4EHPGDPOLB | |
| SCHEMBL8124409 | 0.79 | KDM4E (0.51) | MBOAT4ALDH1A1KDM4EHPGDPOLB | |
| SCHEMBL4813137 | 0.78 | TSHR (0.41) | MBOAT4ALDH1A1KDM4EHPGDGAA | |
| SCHEMBL3276173 | 0.75 | ALDH1A1 (0.39) | MBOAT4ALDH1A1KDM4EHPGDPOLB | |
| SCHEMBL4816582 | 0.74 | MBOAT4 (0.37) | MBOAT4ALDH1A1KDM4EHPGDPDE2A | |
| SCHEMBL23925483 | 0.73 | ALDH1A1 (0.38) | MBOAT4ALDH1A1KDM4EHPGDPOLB | |
| SCHEMBL23944468 | 0.73 | KDM4E (0.43) | ALDH1A1KDM4EHPGDPOLBGAA | |
| SCHEMBL7960580 | 0.73 | ALDH1A1 (0.38) | MBOAT4ALDH1A1KDM4EHPGDPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040097522-A1 | Triazolopyrimidines | BAYER CROPSCIENCE AG (DE) | 2004-05-20 | — | — | US | disclosed |
| EP-1349859-A2 | TRIAZOLOPYRIMIDINES | Bayer CropScience AG (DE) | 2003-10-08 | — | — | EP | disclosed |
| WO-2002050077-A2 | TRIAZOLOPYRIMIDINES | BAYER CROPSCIENCE AG (DE) | 2002-06-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040097522-A1 | Triazolopyrimidines | Q6ZSR9, CYP4X1, DDT | MBOAT4 4399/4885ALDH1A1 373/4885KDM4E 2312/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.